Based in the United States, Cellsonics is a startup.
Cellsonics is developing SimpleFlow™, an automated tissue dissociation system that converts solid tissue into single-cell suspensions while aiming to preserve native gene expression for downstream single-cell analysis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.